Pine River Capital Management’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Pine River Capital Management’s Portfolio STAB Stock Details STAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-150,000	Closed	–	–	478
2016 Q3	$0	Hold	150,000	–	–	﹤0.01%	464
2016 Q2	$0	Hold	150,000	–	–	﹤0.01%	616
2016 Q1	$0	Hold	150,000	–	–	﹤0.01%	818
2015 Q4	$0	Hold	150,000	–	–	﹤0.01%	759
2015 Q3	$0	Hold	150,000	–	–	﹤0.01%	756
2015 Q2	$0	Buy	150,000 +135,000	+900%	+$407K	﹤0.01%	812
2015 Q1	$13K	Buy	+15,000	New	+$61.5K	﹤0.01%	590
2014 Q3	–	Sell	-750	Closed	–	–	1056
2014 Q2	$0	Buy	+750	New	+$8.76K	﹤0.01%	801

Other funds holding STAB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Pine River Capital Management's STAB Position: Q4 2016 in Review

Pine River Capital Management sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q4 2016, closing a stake of 150,000 shares.

Pine River Capital Management first reported a position in STAB in Q2 2014 and held it in 8 quarters. The position peaked at $13K in Q1 2015. 20 funds tracked by Wall St. Rank hold STAB as of Q4 2016.

Pine River Capital Management reported no remaining Statera Biopharma, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Pine River Capital Management sold 150,000 Statera Biopharma, Inc. Common Stock shares in Q4 2016.
Pine River Capital Management first reported a position in Statera Biopharma, Inc. Common Stock in Q2 2014 and held it in 8 quarters.
Pine River Capital Management's Statera Biopharma, Inc. Common Stock position peaked at $13K in Q1 2015.
20 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q4 2016.

Based on Pine River Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.